LOWER EXTREMITY PERIPHERAL ARTERY DISEASE: CONTEMPORARY EPIDEMIOLOGY, MANAGEMENT AND FUTURE TRENDS (A SCIENTIFIC STATEMENT)
Abstract
Lower extremity peripheral artery disease (PAD) affects >230 million adults worldwide and is associated with increased risk of various adverse clinical outcomes (other cardiovascular diseases such as coronary heart disease and stroke and limb outcomes such as amputation). Despite its prevalence and clinical importance, PAD has been historically underappreciated by health care professionals and patients. This underappreciation seems multifactorial (eg, limited availability of the first-line diagnostic test, the ankle-brachial index, in clinics; incorrect perceptions that a leg vascular disease is not fatal and that the diagnosis of PAD would not necessarily change clinical practice). In the past several years, a body of evidence has indicated that these perceptions are incorrect. Several studies have consistently demonstrated that many patients with PAD are not receiving evidence-based therapies. Thus, this scientific statement provides an update for health care professionals regarding contemporary epidemiology (eg, prevalence, temporal trends, risk factors, and complications) of PAD, the present status of diagnosis (physiological tests and imaging modalities), and the major gaps in the management of PAD (eg, medications, exercise therapy, and revascularization). The statement also lists key gaps in research, clinical practice, and implementation related to PAD. Mastermind efforts among different parties (eg, health care providers, researchers, expert organizations, and health care organizations) will be needed to increase the awareness and understanding of PAD and improve the diagnostic approaches, management, and prognosis of PAD.
References
Gerhard-Herman M.D., Gornik H.L., Barrett C. et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017; 135: e726–79. DOI: 10.1161/CIR.0000000000000471.
Hirsch A.T., Criqui M.H., Treat-Jacobson D. et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001; 286: 1317–24. DOI: 10.1001/jama.286.11.1317.
McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015; 116: 1540–50. DOI: 10.1161/CIRCRESAHA.114.303517.
Fowkes F.G., Rudan D., Rudan I. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013; 382: 1329–40. DOI: 10.1016/S0140-6736(13)61249-0.
Agarwal S., Sud K., Shishehbor M.H. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003–2011. J Am Coll Cardiol. 2016; 67: 1901–13. DOI: 10.1016/j.jacc.2016.02.040.
Lijmer J.G., Hunink M.G., van den Dungen J.J. et al. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol. 1996; 22:391–398. DOI: 10.1016/0301-5629(96)00036-1.
Stivalet O., Paisant A., Belabbas D. et al. Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography. PLoS One. 2019; 14: e0219082. DOI: 10.1371/journal.pone.0219082.
Herraiz-Adillo Á., Cavero-Redondo I., Álvarez-Bueno C. et al. The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: a systematic review and meta-analysis. Atherosclerosis. 2020; 315: 81–92. DOI: 10.1016/j.atherosclerosis.2020.09.026.
Allison M.A., Cushman M., Solomon C. et al. Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2009; 50:1049–56. DOI: 10.1016/j.jvs.2009.05.061.
Aboyans V., Lacroix P., Tran M.H. et al. The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease. J Vasc Surg. 2011; 53: 984–91. DOI: 10.1016/j.jvs.2010.10.054.
Misra S., Shishehbor M.H., Takahashi E.A. et al. on behalf of the American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; and Council on Cardiovascular and Stroke Nursing. Perfusion assessment in critical limb ischemia: principles for understanding and the development of evidence and evaluation of devices: a scientific statement from the American Heart Association. Circulation. 2019; 140: e657–72. DOI: 10.1161/CIR.0000000000000708.
Kumamaru K.K., Hoppel B.E., Mather R.T., Rybicki F.J. CT angiography: current technology and clinical use. Radiol Clin North Am. 2010; 48: 213–35, vii. DOI: 10.1016/j.rcl.2010.02.006.
Buls N., de Brucker Y., Aerden D. et al. Improving the diagnosis of peripheral arterial disease in below-the-knee arteries by adding time-resolved CT scan series to conventional run-off CT angiography. First experience with a 256-slice CT scanner.Eur J Radiol. 2019; 110: 136–41. DOI: 10.1016/j.ejrad.2018.11.030.
Hur S., Jae H.J., Jang Y. et al. Quantitative assessment of foot blood flow by using dynamic volume perfusion CT technique: a feasibility study. Radiology. 2016; 279: 195–206. DOI: 10.1148/radiol.2015150560.
Sah B.R., Veit-Haibach P., Strobel K. et al. CT-perfusion in peripheral arterial disease – correlation with angiographic and hemodynamic parameters. PLoS One. 2019; 14: e0223066. DOI: 10.1371/journal.pone.0223066.
Allard L., Cloutier G., Durand L.G. et al. Limitations of ultrasonic duplex scanning for diagnosing lower limb arterial stenoses in the presence of adjacent segment disease. J Vasc Surg. 1994; 19: 650–7. DOI: 10.1016/s0741-5214(94)70038-9.
Hou X.X., Chu G.H., Yu Y. Prospects of contrast-enhanced ultrasonography for the diagnosis of peripheral arterial disease: a meta-analysis. J Ultrasound Med. 2018; 37: 1081–90. DOI: 10.1002/jum.14451.
Kuchay A.A., Lipin A.N., Antropov A.V. et al. Treatment of multilevel lesions of arteries in lower extremities in cases of CLTI. Medical Alliance. 2022; 10(S3): 187–9. EDN IWSMIP.
Serhal A., Koktzoglou I., Edelman R.R. Feasibility of image fusion for concurrent MRI evaluation of vessel lumen and vascular calcifications in peripheral arterial disease. AJR Am J Roentgenol. 2019; 212: 914–8. DOI: 10.2214/AJR.18.20000.
US Preventive Services Task Force: Curry S.J., Krist A.H., Owens D.K. et al. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US Preventive Services Task Force recommendation statement. JAMA. 2018; 320: 177–83. DOI: 10.1001/jama.2018.8357.
Kuchay A.A., Lipin A.N., Karelina N.R., Artyukh L.Yu. Revascularization of lower limb based on the angiosome concept with early local flap reconstruction (A CASE REPORT). Forcipe. 2022; 5(4): 29–35.
Conte M.S., Pomposelli F.B. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg. 2015; 61(3 suppl): 1S. DOI: 10.1016/j.jvs.2014.12.006.
Lindholt J.S., Søgaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet. 2017; 390: 2256–65. DOI: 10.1016/S0140-6736(17)32250-X.
Ortmann J., Nüesch E., Traupe T. et al. Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemia. J Vasc Surg. 2012; 55: 98–104. DOI: 10.1016/j.jvs.2011.07.074.
Pande R.L., Creager M.A. Socio economic inequality and peripheral artery disease prevalence in US adults. Circ Cardiovasc Qual Outcomes. 2014; 7: 532–9. DOI: 10.1161/CIRCOUTCOMES.113.000618.
Kuchay A.A., Lipin A.N., Karelina N.R. et al. Revascularization in extended occlusions of the superficial part of the femoral artery and multi-storey lesions of the arteries of the lower extremity. Forcipe. 2022; 5(3): 4–14.
Zhang P., Lu J., Jing Y. et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017; 49: 106–16. DOI: 10.1080/07853890.2016.1231932.
Hinchliffe R.J., Forsythe R.O., Apelqvist J. et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020; 36(suppl 1): e3276. DOI: 10.1002/dmrr.3276.
Morbach S., Furchert H., Gröblinghoff U. et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012; 35: 2021–7. DOI: 10.2337/dc12-0200.
Bevilacqua N.J., Rogers L.C., Armstrong D.G. Diabetic foot surgery: classifying patients to predict complications. Diabetes Metab Res Rev. 2008; 24(suppl 1): S81–3. DOI: 10.1002/dmrr.858.
Kuchay A.A., Lipin A. N., Antropov A.V. et al. Hybrid approach in treatment of extended occlusive arteries of the lower extremities in CLTI. Angiology and vascular surgery; 2019; 25(S2): 260–4.
Willigendael E.M., Teijink J.A., Bartelink M.L. et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg. 2004; 40: 1158–65. DOI: 10.1016/j.jvs.2004.08.049.
Leng G.C., Lee A.J., Fowkes F.G. et al. The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study. Eur Heart J. 1995; 16: 1542–8. DOI: 10.1093/oxfordjournals.eurheartj.a060775.
Tsimikas S., Karwatowska-Prokopczuk E., Gouni-Berthold I. et al. AKCEA-APO(a)-LRx Study Investigators. Lipoprotein(a) reduction in persons with cardiovascular disease. N Engl J Med. 2020; 382: 244–55. DOI: 10.1056/NEJMoa1905239.
Kuchay A.A., Lipin A. N., Antropov A.V. et al. Treatment for multistory lesions of lower extremities in CLTI. Angiology and vascular surgery; 2021; 27(S2): 410–2.
Aday A.W., Lawler P.R., Cook N.R. et al. Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence. Circulation. 2018; 138: 2330–41. DOI: 10.1161/CIRCULATIONAHA.118.035432.
Bhatt D.L., Steg P.G., Miller M. et al; REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia.N Engl J Med. 2019; 380: 11–22. DOI: 10.1056/NEJMoa1812792.
Chowdhury R., Ramond A., O’Keeffe L.M. et al. Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2018; 362: k3310. DOI: 10.1136/bmj.k3310.
Hoffmann B., Moebus S., Kröger K. et al. Residential exposure to urban air pollution, ankle-brachial index, and peripheral arterial disease. Epidemiology. 2009; 20: 280–8. DOI: 10.1097/EDE.0b013e3181961ac2.
Ruo B., Liu K., Tian L. et al. Persistent depressive symptoms and functional decline among patients with peripheral arterial disease. Psychosom Med. 2007; 69: 415–24. DOI: 10.1097/PSY.0b013e318063ef5c.
Kuchay A.A., Lipin A. N., Antropov A.V. et al. Concept of a “DISTAL HYBRID” for long occlusions of the superficial femoral artery with severe damage to the outflow pathways at critical ischemia of the lower extremity. Angiology and vascular surgery. 2022; 28(S1): 157–61.
Yang C., Kwak L., Ballew S.H. et al. Retinal microvascular findings and risk of incident peripheral artery disease: an analysis from the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2020; 294: 62–71. DOI: 10.1016/j.atherosclerosis.2019.10.012.
Collins T.C., Lunos S., Carlson T. et al. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care. 2011; 34: 2174–9. DOI: 10.2337/dc10-2399.
McDermott M.M., Spring B., Tian L. et al. Effect of low-intensity
vs high-intensity home-based walking exercise on walk distance
in patients with peripheral artery disease: the LITE randomized
clinical trial. JAMA. 2021; 325: 1266–76. DOI: 10.1001/jama.2021.2536.
Giacoppo D., Cassese S., Harada Y. et al. Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials. JACC Cardiovasc Interv. 2016; 9: 1731–42. DOI: 10.1016/j.jcin.2016.06.008.
Kuchay A.A., Lipin A. N., Antropov A.V. et al. Hybrid approach to long occlusion of SFA with CLTI. Angiology and vascular surgery. 2022; 28(S1): 161–3.
Rosenfield K., Jaff M.R., White C.J. et al. LEVANT 2 Investigators. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015; 373: 145–53. DOI: 10.1056/NEJMoa1406235.
Kurianov P., Lipin A., Antropov A. et al. Popliteal artery angioplasty for chronic total occlusions with versus without the distal landing zone. Annals of vascular surgery; 2020; 62(68): 417–25.
Copyright (c) 2023 Russian Biomedical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
